Cazoshay Marie's life changed in an instant when she was struck by a car at 48 MPH, leading to a traumatic brain injury.

Since the approval of Luxturna, there has been a wave of gene therapies advancing in clinical trials to treat genetic vision ...

SpliceBio has closed a Series B financing round, raising $135m for the clinical development of SB-007 for Stargardt disease.

For decades, the dominant treatment approaches for substance use disorder have centered around identifying past deficits and unpacking trauma. SFT offers a compelling alternative.

Medera is a clinical-stage biopharmaceutical company focused on targeting difficult-to-treat and currently incurable diseases ...

In this Healio Video Perspective from the ARVO meeting, SriniVas R. Sadda, MD, FARVO, discusses a long-term study evaluating MCO-010 for the treatment of retinitis pigmentosa.

Autograph Collection Hotels makes its debut in South Asia with the opening of The Soaltee Kathmandu, Autograph Collection in ...

The researchers utilised the power of light and a dye named Rose Bengal to develop a unique treatment for Acanthamoeba ...

Discover Earth’s breathtaking beauty in this ultra high-definition travel film, captured in 8K with Dolby Vision™ and paired ...

Striking a balance between life extension and patient values challenges doctors to view treatment refusal as a valid choice, ...

Older adults with diabetes who are using semaglutide are twice as likely to develop neovascular age-related macular ...

Funding will support the continued clinical advancement of its lead ocular implant candidate, PA5108, for the reduction of ...